Group B Streptococcus (GBS) is considered the leading bacterial cause of neonatal infections and meningitis is the most serious manifestation. Its clinical manifestations are usually non-specific and its signs and symptoms may be subtle, unspecific, vague, atypical or absent. We report six clinical cases of GBS meningitis with early onset in three infants (first week of life) and late onset (after 1 month of life) in the remaining three. Prenatal GBS screening, performed on four infants, resulted positive only in one case. Cerebral ultrasonography showed high sensitivity in detecting early meningeal involvement confirmed by MRI in all infants. Our study describes the clinical characteristics, antibiotic sensitivity and outcome of the six cases. The results of our analysis emphasize the severity of GBS meningitis and show that cerebrovascular involvement is a common but poorly studied pathologic process in GBS meningitis. In addition, cranial ultrasonography plays an important role in detecting infarctions, cerebritis, hemorrhages or abscesses and in monitoring complications. Neonates with GBS meningitis are prone to adverse outcomes or sequelae. Mortality in GBS meningitis approaches 30% and neurologic sequelae are present in 25% of cases.
Introduction
Group B Streptococcus (GBS) is the leading bacterial cause of serious infections in the neonatal period, along with E. coli and L. monocytogenes; GBS is responsible for 70-80% of bacterial meningitis [1] . GBS is a Gram-positive encapsulated commensal bacterium of the human intestine, which is also present in 15-30% of healthy women's vaginas. Fifty percent of infants born from colonized mothers are asymptomatic at birth, but only 1% of them develop invasive disease (sepsis, meningitis, pneumonia, osteomyelitis, septic arthritis, cellulitis, and otitis) [2] . GBS infections can be classified as an early-onset disease (EOD), occurring within the first week of life, and late-onset disease (LOD), between the second week and 3 months of age.
Clinical features of GBS meningitis
GBS meningitis is considered the most serious manifestation of LOD infection, although sometimes it can occur earlier, just a few hours after birth. Together with Gram-negative infections, GBS has the worst prognosis.
The early symptoms may be unspecific and include temperature instability, feeding difficulties, excessive crying or irritability, respiratory distress. Signs and symptoms of meningitis may be subtle, unspecific, vague, atypical or absent. The early signs and symptoms of neonatal meningitis are similar to those of septicemia: lethargy, feeding problems, altered temperature, respiratory distress, apnea, jaundice and abdominal distention. Further on, stiff neck, hypo/hypertonia, bulging fontanel and seizure may appear.
Pathogenesis
GBS is classified into eight serotypes (Ia, II, III, IV, V, VI, VII, and VIII) on the basis of capsular polysaccharide and presence/ absence of c and R protein antigens. The EOD can be caused by all serotypes while serotype III is the one most responsible for LOD (90% of cases) [3] [4] [5] . Furthermore, serotype III is the one mainly responsible for cases of GBS meningitis, regardless of the age at onset of infection [6] . The development of GBS meningitis reflects the ability of the bacteria to invade the microvascular endothelial cells of the human brain (brain microvascular endothelial cells (BMECs)). The first step in the pathogenesis of meningitis consists of the interaction between GBS and BMECs. GBS can gain access through the CNS by direct lysis of BMECs with consequent endothelial damage, inflammation and disruption of the integrity of the BBB or, alter-
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Int J Clin Pediatr. 2015;4(1):127-136 natively, by bacterial transcytosis. Several virulence factors are thought to be involved in the pathogenesis of meningitis: SRR1 and SRR2 (serine-rich repeat glycoprotein) [7, 8] , the HvgA (hypervirulent GBS adhesin) [9] , the Lmb (laminin-binding protein), and LagA (lipoteichoic acid anchoring enzyme) [10] . Reactive nitrogen species are the most important mediators of brain inflammation [11] . Eventually, GBSs can reach the brain through choroid plexus or intraventricular hemorrhage [11] .
Diagnosis
The analysis of cerebrospinal flow (CSF) is the gold standard for the diagnosis of GBS meningitis.
Cranial ultrasonography (US) plays an important role in the initial evaluation of an infant with suspected bacterial meningitis as well as in monitoring all possible complications. Yikilmaz et al [12] recommend cranial US as a first study in infants who have an adequate size of fontanel if there is a clinical suspect of bacterial meningitis. MRI should be the next study of choice [12] .
Prognosis and outcome
Mortality of GBS meningitis approaches 30% [13] and longterm evaluation of infants who survive GBS meningitis indicates that 30% of cases have mild-to-moderate neurologic sequelae and 19% have severe sequelae with global cognitive delay, cerebral palsy, cortical blindness, and/or hearing impairment [14] .
Cranial US

Initial sonographic anomalies (hours or few days)
1) Brain swelling with slitlike lateral ventricles and swollen and hyperechoic choroid plexus due to plexitis.
2) Hyperechoic sulci and increased echogenicity of the cortex related to exudation.
Possible evolution in an intermediate stage (second week)
1) Dense ventricular lining due to ependymitis.
2) Inhomogeneous echogenicity in the white matter due both to inflammation and infarction.
3) Thalami and basal ganglia nodular focal infarcts due to thrombophlebitis.
4) Initial subtle intraventricular strand formation (ventriculitis).
Advanced stage
Periventricular, intermediate and subcortical cysts due to com- bination of infection and venous infarction.
Complications
1)
Widening of the ventricles due to obstruction of CSF evolving into hydrocephalus.
2) Subdural effusion, either sterile or purulent, which appears as round biconvex collection.
Case Reports
We describe six case reports of GBS meningitis: three cases of EOD and three cases of LOD. The population is summarized in Table 1 . Case details are provided below. Prenatal GBS screening through vagino-rectal swab was performed in four cases: it resulted negative in three cases and positive in one case. In two cases (one preterm and one term newborn), the screening was not performed.
Median age at onset of symptoms was 23.1 days (range 1 -63 days).
Case 1
A preterm female newborn (32 weeks, 1,485 g), second of triplets, was born from a healthy mother. GBS screening was 
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Int J Clin Pediatr. 2015;4(1):127-136 not performed. She was admitted to neonatal intensive care unit (NICU) and discharged 1 month later in a good general state. At about 2 months of age, she was readmitted for fever, septic, bulging bregmatic fontanel, stiff neck and high-pitched cry, followed by seizure. The initial blood test revealed leukopenia (WBC 2,400/mmc; N 1.27%), increased C-reaction protein (CRP, > 200 mg/L) and procalcitonin (PCT, > 100 ng/ mL), positive blood and CSF culture for GBS. CSF revealed pleocytosis (160 cell/µL) and increased protein (111 mg/dL). Treatment with ampicillin, gentamicin and ceftazidime was started. The course of disease was complicated by SIADH (Na 121 mEq/L). To treat seizure, sodium supplementation and anticonvulsant therapy were required. Cranial US revealed echogenic widening of brain sulci and interhemispheric fissure associated with meningeal thickening together with mild ventricular enlargement (Fig. 1 ). Brain MRI revealed frontal bilateral subdural effusions (Fig. 2) . The infant was transferred to a neurosurgical unit to drain the collections. Neurological evaluation at 4 years of age demonstrated no global delay and no visual or auditory impairment.
Case 2
A term female newborn (39 weeks, PN 3,360 g) was born by vaginal delivery after physiologic gestation. GBS screening was performed at 35th and 37th week and resulted negative. At 4 days of life, she was admitted to the NICU for fever, feeding intolerance, poor perfusion, hypotonia, whiny crying and seizure. Immediate treatment with double anticonvulsant therapy was started. The initial blood analysis revealed increased CRP (107 mg/L) and PCT (9.85 ng/mL) and positive blood culture. Nasal and pharyngeal swabs and CSF culture were positive for GBS. Triple antibiotic (ampicillin, gentamicin and ceftazidime) treatment was started. The first cranial US (Fig.  3 ) was performed at 4 days of life. US revealed a markedly hyperechoic right thalamus and basal ganglia. After 2 days a second scan showed another echodensity within the caudate head (Fig. 3) . Subsequently, multiple foci of cortical and subcortical hyperechogenicities were observed (Fig. 4) . The last scan, performed at 2 months of life, revealed an irregular and asymmetrical ventricular enlargement with a notch of ependyma just above the left thalamus (Fig. 5) . MRI (Fig. 6 ) demonstrated ventriculitis and bilateral basal ganglia and frontal ischemic lesions which evolved into multiple cysts in 20 days. Neurological evaluation at 1 and 4 months demonstrated normal findings.
Case 3
A preterm female (32 weeks, 2,150 g) was born after gestation complicated by gestational diabetes. SGB screening was negative. She was admitted to the NICU and discharged 1 month later in a good general state. Four days later, because of the onset of fever, she was brought in for care. The initial blood analysis revealed leukocytosis, increased CRP (100 mg/L) and PCT (36 ng/mL) and positive blood culture for GBS. CSF analysis demonstrated pleocytosis (400 cell/µL), hypoglycor- Cranial US (Fig. 7) revealed widening of the subarachnoid space with hyperechoic debris content. MRI demonstrated widening supratentorial liquoral spaces, subdural collections and left transversal sinus thrombosis (Fig. 8) .
The infant was transferred to a neurosurgical unit to drain the empyema. The neurological evaluation at 3 years of age demonstrated no global delay and no visual or auditory impairment.
Case 4
A term female newborn (38 weeks, 2,280 g) was born by cesarean section 12 h after membrane rupture. GBS screening was not performed. The mother had an uneventful pregnancy. At 3 days of life, the newborn manifested fever, poor general conditions, poor perfusion, whiny crying and feeding intolerance. She was admitted to the NICU. The initial blood analysis revealed leukocytosis (WBC 27,700/mmc; N 87%), increased CRP (270 mg/L), PCT (104 ng/mL) and presepsine (3,432 pg/ mL). Blood culture, nasal and pharyngeal swabs were positive for GBS. Initially, the CSF analysis was not performed. Double antibiotic treatment was started. Cranial US revealed a very low resistance index (RI = 0.35) and right frontal periventricular echodensity (Fig. 9, 10 ). Twenty-four hours later, she developed generalized hypertonia and clonic seizure that resolved with double-drug anticonvulsant therapy. The CSF analysis revealed hypoglychorrachia (15 mg/dL), pleocytosis (1,920 cell/mmc with predominant neutrophils), and increased protein (403 mg/dL); CSF culture was positive for GBS. Because of the clinical deterioration, cranial US was repeated; it revealed asymmetric widening of lateral ventricles [12] [13] [14] [15] , single and localized echodensity in the left thalamus (Fig. 11-13 ) and a single intraventricular strand (Fig. 12, 14) , followed in the last scan by obstructive triventricular hydrocephalus and bilateral frontal cysts (Fig. 15-18) . MRI (Fig. 19) demonstrated the presence of frontal and parietal white matter cysts, abnormal signal of frontal, parietal and deep gray matter (putamen and pallidus). Because of the evolving hydrocephalus, the infant was transferred to the neurosurgical unit. The clinical evaluation at 50 days of life showed increased muscle tone. 
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Case 5
A male term newborn (39 weeks, 3,190 g) was born by vaginal delivery after an uneventful pregnancy. GBS screening was negative at 37 weeks' gestation. A few hours later, because of the development of pale cyanosis followed by fever and hyperreactivity, he was admitted to the NICU. The initial blood analysis revealed leukopenia (WBC 3,100/mmc; 75% neutrophils), increased CRP (168.9 mg/L) and PCT (21.5 ng/mL). CSF demonstrated pleocytosis (420 cell/mmc), hypoglycorrhachia (3 mg/dL), and increased protein (420 mg/ dL); CSF and the blood culture were positive for GBS. Triple-antibiotic therapy was started. The first cranial US was completely normal (Fig. 20) ; 3 days later, the scan showed a mild widening of interhemispheric fissure with subarachnoid echogenic strands (Fig. 21) , particularly severe near the occipital regions (Fig. 22) , asymmetric lateral ventricles, rounded echodensity in the left thalamus and incipient cavitation of both left caudate nucleus and thalamus (Fig. 23) . MRI revealed small hemorrhages in the thalami and right transversal sinus thrombosis together with ischemic-hemorrhagic foci in the frontal subcortical white matter bilaterally (no available image).
Case 6
The last girl was born at term (39 weeks, 3,070 g) by vaginal delivery after a physiologic pregnancy. GBS screening was positive; a single dose of antibiotic (ampicillin) was given to the mother a few hours before giving birth. At 25 days of life, because of the development of fever and feeding intolerance, the newborn was brought in for care. She presented poor perfusion, decreased level of consciousness, hypotonia and seizure.
The initial blood analysis revealed leukopenia (WBC 2,500/ mmc; 45% neutrophil and 51% lymphocytes), hypoglycemia (36 mg/dL), increase PCT (338.5 ng/mL) and presepsine (762 pg/mL). CSF revealed hypoglycorrhachia (3 mg/dL), absence of cells, increased protein concentration (283 mg/dL). CSF and blood culture were positive for GBS. Double antibiotic (gentamicin, ampicillin + sulbactam) therapy was started. Cranial sonography demonstrated hyperechoic sulci between the gyri (no available images). Progressively, she worsened and 
Discussion
GBS is the main bacterial cause of serious infection in newborns. The guidelines for the prevention of perinatal GBS disease provided by the CDC (Centers for Disease Control and Prevention) in 2002, recommend performing rectal and vaginal swabs between the 35th and 37th week of gestation and intrapartum antibiotic prophylaxis (IAP) in colonized women [15] . According to the American Academy of Pediatrics [4] , IAP has managed to reduce by 80% the incidence of GBS EODs, but has not shown significant efficacy in the prevention of LODs [9] . The vagino-rectal swab identifies the presence of GBS in 54-87% of cases and it is therefore possible to have some false negatives [16] : in our study GBS screening was negative in three cases. The maternal status for GBS cannot be used as the only risk factor for GBS EOD and LOD. Furthermore, it is important to emphasize that the guidelines recommend vagino-rectal swab performance between the 35th and 37th weeks. As a consequence, in the case of a premature birth, maternal GBS status may be unknown [17] . Horizontal transmission and environmental sources (nosocomial and familiar) are the main causes of GBS LOD; thus, the association of vagino-rectal swab and LOD is controversial. GBS meningitis is considered the most serious manifestation of LOD infection, but sometimes it can occur in the first week of life: in our study, meningitis was a manifestation of LOD in three newborns but in the other three cases, meningeal involvement occurred in the first week of life; one of them developed this condition just a few hours after birth.
Cranial US is an important tool for the initial evaluation of an infant with suspected neonatal meningitis and for monitoring its evolution. Although in the earliest stages the findings may be normal (as in our case 5), US may detect the presence of edema, ventriculitis, liquoral space widening, subdural effusion, focal or diffuse parenchymal involvement by cerebritis, infarction, hemorrhages or abscesses. Contemporary long-term outcomes for children surviving GBS meningitis reveal that 56% are functioning normally. The remainder undergoes mild-to-moderate (25%) or severe (19%) neurodevelopmental impairment [18] such as cerebral palsy, language and cognitive impairments, deafness, vision disorders, epilepsy and hydrocephalus. Unfortunately in some cases, the infant dies despite early therapy.
Conclusions
Because of the serious adverse neurological outcomes of GBS meningitis, there is the need for prevention of GBS infections and for ongoing developmental follow-up for GBS meningitis survivors. 
